Beginning in an era when female scientists were a lonely minority, women have made major contributions to our understanding of Haemophilus influenzae type b (Hib) as a pathogen, its treatment and its prevention. The individual scientific and public health contributions, and their collective impact, are reviewed in the context of the development and successful implementation of highly efficacious Hib vaccines that are now being deployed to nearly every country worldwide for the prevention of life-threatening pediatric Hib disease.
From the *Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD; and †Division of Infectious Diseases, Department of Medicine, Children’s Hospital Boston and Harvard Medical School, Boston, MA.
Accepted for publication October 31, 2013.
The authors have no conflicts of interest to disclose.
Address for correspondence: Katherine O’Brien, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, 855 N. Wolfe Street, Suite 600, Baltimore, MD 21205. E-mail: firstname.lastname@example.org.